Genetics of programmed cell death in C. elegans: Past, present and future
Metzstein, M.M., Stanfield, G.M. & Horvitz, H.R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 14, 410-416 (1998).
The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis
Schumacher, B., Hofmann, K., Boulton, S. & Gartner, A. The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Curr. Biol. 11, 1722-1727 (2001).
Identification of a novel inhibitor of nuclear factor-kB, RelA-associated inhibitor
Yang, J.-P., Hori, M., Sanda, T. & Okamoto, T. Identification of a novel inhibitor of nuclear factor-kB, RelA-associated inhibitor. J. Biol. Chem. 274, 15662-15670 (1999).
Transcription activation by p53 correlates with suppression of growth but not transformation
Crook, T., Marston, N.J., Sara, E.A. & Vousden, K.H. Transcription activation by p53 correlates with suppression of growth but not transformation. Cell 79, 817-827 (1994).
E2F1-induced apoptosis requires DNA binding but not transcriptional activity and is inhibited by the retinoblastoma protein through direct interaction
Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K. & Lu, X. E2F1-induced apoptosis requires DNA binding but not transcriptional activity and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11, 1840-1852 (1997).